Recombinant multi-species IL-11/IL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-11/IL11 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the gp130 family of cytokines. These cytokines drive the assembly of multisubunit receptor complexes, all of which contain at least one molecule of the transmembrane signaling receptor IL6ST (gp130). This cytokine is shown to stimulate the T-cell-dependent development of immunoglobulin-producing B cells. It is also found to support the proliferation of hematopoietic stem cells and megakaryocyte progenitor cells. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
The Alternative Names of target: AGIF,Adipogenesis inhibitory factor (AGIF),IL-11,IL11,Il-11,Il11,Interleukin-11
Go
to IL-11/IL11 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T56308-Ag-1/ GM-Tg-hg-T56308-Ag-2 | Human IL-11/IL11 protein | Human |
| GM-Tg-rg-T56308-Ag-1/ GM-Tg-rg-T56308-Ag-2 | Rat IL-11/IL11 protein | Rat |
| GM-Tg-mg-T56308-Ag-1/ GM-Tg-mg-T56308-Ag-2 | Mouse IL-11/IL11 protein | Mouse |
| GM-Tg-cynog-T56308-Ag-1/ GM-Tg-cynog-T56308-Ag-2 | Cynomolgus/Rhesus macaque IL-11/IL11 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T56308-Ag-1/ GM-Tg-felg-T56308-Ag-2 | Feline IL-11/IL11 protein | Feline |
| GM-Tg-cang-T56308-Ag-1/ GM-Tg-cang-T56308-Ag-2 | Canine IL-11/IL11 protein | Canine |
| GM-Tg-bovg-T56308-Ag-1/ GM-Tg-bovg-T56308-Ag-2 | Bovine IL-11/IL11 protein | Bovine |
| GM-Tg-equg-T56308-Ag-1/ GM-Tg-equg-T56308-Ag-2 | Equine IL-11/IL11 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T56308-Ag-1/ GM-Tg-hg-T56308-Ag-2;
GM-Tg-rg-T56308-Ag-1/ GM-Tg-rg-T56308-Ag-2;
GM-Tg-mg-T56308-Ag-1/ GM-Tg-mg-T56308-Ag-2; GM-Tg-cynog-T56308-Ag-1/ GM-Tg-cynog-T56308-Ag-2; GM-Tg-felg-T56308-Ag-1/ GM-Tg-felg-T56308-Ag-2; GM-Tg-cang-T56308-Ag-1/ GM-Tg-cang-T56308-Ag-2; GM-Tg-bovg-T56308-Ag-1/ GM-Tg-bovg-T56308-Ag-2; GM-Tg-equg-T56308-Ag-1/ GM-Tg-equg-T56308-Ag-2 |
| Products Name | IL-11/IL11 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | IL-11/IL11 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-11/IL11 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.